Banlota, Daisy A.

HRN: 15-36-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/28/2023
03/06/2023
IVT
500mg
Q8
Amoebiasis
Waiting Final Action 
02/28/2023
CEFUROXIME 1.5GM (VIAL)
02/28/2023
03/06/2023
IV
1.5gram
Q8
Complicated UTI
02/28/2023
CEFTRIAXONE 1G (VIAL)
02/28/2023
03/06/2023
IV
2g
OD
Complicated UTI
Waiting Final Action 
03/01/2023
METRONIDAZOLE 500MG (TAB)
03/01/2023
03/08/2023
PO
500mg
TID
Infectious Diarrhea
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: